Aaditya Thackeray slams Shinde-Fadnavis Government as Maharashtra loses two mega projects to Gujarat

The Bulk Drug Park (BDP), another massive project sought by the previous MVA government, has also gone to Gujarat, Andhra Pradesh, and Himachal Pradesh, attracting criticism from Maharashtra’s opposition. In addition to the Foxconn-Vedanta semiconductors plant.

Shiv Sena leader Aaditya Thackeray has blamed the Shinde-Fadnavis government for the loss of the mega projects.“The then CM Uddhav Thackeray had written to the Centre requesting the BDP project in Maharashtra. We had followed it up with the Centre and hoped to get it. The project would have generated 70,000 job opportunities in the state. We had even finalized the location in Raigad district that was close to airports and ports,” said Aditya.

“Meanwhile, we lost the government and the new unconstitutional dispensation failed to pursue it. We have now learnt that the BDP project has gone to Gujarat,” he said. “I believe every state should get its fair share of investment, and job opportunities. I don’t complain about the three states bagging the project. Yet I wonder why the current Maharashtra dispensation could not actively pursue the project with the Centre,” he said.

Aaditya Thackeray, the former tourism and environment minister in the MVA government that his father Uddhav Thackeray led, slammed the current Shinde-Fadnavis-led administration by saying that Maharashtra had lost two significant opportunities that could have easily created one lakh jobs as a result of the Foxconn-Vedanta semiconductor project moving to Gujarat.

“The current government is indulging in mudslinging, but has no answer for the youth who lost out on job opportunities,” he said.“We have 350 pharmaceutical colleges in Maharashtra. Besides, the climate for business is also good and we have other connected drug firms in Pune. We missed a great opportunity due to the non-performance of the Shinde government,” Thackeray said.

The creation of a strong ecosystem for bulk medication manufacturing in the nation will result from the provision of common infrastructural facilities at the Bulk Drug Parks, which will drastically lower the cost. This programme is anticipated to promote domestic production of bulk medications decrease reliance on imports and develop a commanding presence on the international market by facilitating simple access to infrastructure and standard testing facilities.